# EDETATE CALCIUM DISODIUM
> **ANDA216435** · Abbreviated New Drug Application (Generic) · Sponsor: CASPER PHARMA LLC · Approved 2023-05-03
## Drug
- **FDA Application Number:** ANDA216435
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EDETATE CALCIUM DISODIUM
- **Generic name:** EDETATE CALCIUM DISODIUM
- **Active ingredients:** EDETATE CALCIUM DISODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CASPER PHARMA LLC
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2023-05-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216435)
---
*AI Analytics · CC0 1.0*